Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Germany
- Sweden
- Spain
- Netherlands
- Denmark
- Portugal
- France
- Czech
- Belgium
- Canada
- Australia
- Poland
- Finland
- Hong Kong
- Luxembourg
- Singapore
- Vietnam
- Ireland
- Italy
- Switzerland
- United Arab Emirates
- Austria
- Brazil
- China
- Croatia
- Greece
- India
- Japan
- Macau
- Mexico
- Norway
- Romania
- Taiwan
- Turkey
- 26 more »
- « less
-
Program
-
Field
-
doctoral candidates in 9 European countries. The STEM-CORE Marie Skłodowska-Curie Actions programme aims to explore strategies for developing stem cell therapies and biomaterials. As one of the doctoral
-
University of Texas Health Science Center San Antonio | San Antonio, Texas | United States | about 16 hours ago
independent investigator committed to innovative research in stem cells and regenerative medicine and its clinical application, with the vision and administrative acumen to leverage the Center’s resources
-
medical benefits, holiday pay and sick leave accrual. In consultation with the Biomedical Sciences (BMS) and Developmental and Stem Cell Biology (DSCB) Graduate Program Manager, the BMS/DSCB Program
-
cells into specialized cell-types. To help address this challenge, the Loh Laboratory (https://loh.stanford.edu/ ) at the Institute for Stem Cell Biology & Regenerative Medicine and the Department
-
ICETA - Instituto de Ciências, Tecnologias e Agroambiente da Universidade do Porto | Portugal | 3 months ago
biomaterials, assessing the functional activity of mesenchymal stem cells in contact with innovative biomaterials; Participation in conducting and monitoring in vivo studies involving animal models of different
-
modelling, stem cell biology (animal-/humanderived tissues), micro-physiological systems (MPS), organ-on-chip, zoonotic diseases, drug/vaccine testing and validation for zoonotic diseases, machine learning in
-
cells into specialized cell-types. To help address this challenge, the Loh Laboratory (https://loh.stanford.edu/ ) at the Institute for Stem Cell Biology & Regenerative Medicine and the Department
-
pancreatic cancer stem cell properties and in vivo metastasis (iScience 2025, doi: 10.1016/j.isci.2025) Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance
-
disease. This ambitious project focuses on the creation and validation of innovative preclinical models — including primary neuronal cultures, neurons derived from induced pluripotent stem cells (iPSCs
-
Therapy Financial Counselor II is responsible for coordinating all financial phases of Stem cell transplant and Immune Effector Cell (IEC) therapy at Dana Farber Cancer Institute and its partner facilities